Trial Profile
Clinical Trials Insight: 700024264
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 21 Jul 2011
Price :
$35
*
At a glance
- Drugs Obinepitide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors 7TM Pharma
- 29 Nov 2007 Results are expected in the first quarter of 2008.
- 02 Jul 2007 New trial record.